Content about McKesson Specialty Health

August 28, 2013

McKesson Specialty Health and The US Oncology Network on Wednesday announced the appointment of Michael Seiden as chief medical officer, effective Sept, 22.

THE WOODLANDS, Texas — McKesson Specialty Health and The US Oncology Network on Wednesday announced the appointment of Michael Seiden as chief medical officer, effective Sept, 22. 

September 24, 2012

McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately.

SAN FRANCISCO — McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately. Walchirk, who most recently was chief operating officer of McKesson Specialty Health, has held numerous leadership roles at McKesson over the past 11 years, including COO of McKesson U.S. Pharmaceutical.

September 12, 2011

McKesson on Monday announced the creation of a new division: McKesson Specialty Health.

THE WOODLANDS, Texas — McKesson on Monday announced the creation of a new division: McKesson Specialty Health.

Less than a year ago, McKesson Corporation acquired US Oncology with a vision of enhancing its customer offerings. Through integrated technology offerings, including iKnowMed, a top-ranked Web-based oncology electronic health record, and the Lynx Mobile drug inventory management system, McKesson Specialty Health hopes to improve the financial health of its customers, while empowering them to advance the science, quality and efficiency of patient care.